Siga Technologies INC Liabilities Assumed
Siga Technologies INC (SIGA) reported Liabilities Assumed of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2019-03-06
- Siga Technologies INC liabilities assumed for the quarter ending 2017-12-31 was $5.83M.
- Siga Technologies INC liabilities assumed for the quarter ending 2017-09-30 was $0.00.
- Siga Technologies INC liabilities assumed for the quarter ending 2016-12-31 was $0.00.
- Siga Technologies INC liabilities assumed for the quarter ending 2015-12-31 was $0.00.
- Siga Technologies INC liabilities assumed for fiscal 2018 was $0.00.
- Siga Technologies INC liabilities assumed for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Siga Technologies INC liabilities assumed for fiscal 2016 was $5.83M.
- Siga Technologies INC liabilities assumed for fiscal 2015 was $0.00.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-06 | |||
| 2017-12-31 | $5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $5.83M derived: sum of 2 quarters · filed 2019-03-06 | $0.00 10-K · filed 2019-03-06 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 | -$5.83M 10-Q · filed 2017-11-07 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $5.83M 10-K · filed 2019-03-06 | ||
| 2016-09-30 | $5.83M 10-Q · filed 2016-11-02 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $0.00 10-K · filed 2018-03-06 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-02 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |